CD4 and neoplasm: To evaluate the potential role of Tregs and its subsets in human GC, we first gated CD4+CD25+Foxp3+ T lymphocytes as Tregs and analyzed the Treg percentage within the total CD4+ T-cell populations from peripheral blood, non-tumor, peritumoral, and tumor tissues of GC patients.